Lapenoria, Gloden .

HRN: 24-88-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2024
CEFUROXIME 1.5GM (VIAL)
04/18/2024
04/19/2024
IV
1.5gm
Q8 X 4doses
Prophylaxis
Waiting Final Action 
04/18/2024
CEFUROXIME 500MG (TAB)
04/19/2024
04/26/2024
PO
500mg Tab
BID
Post OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: